Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Endometrial Neoplasms 5Endometrial Hyperplasia 3Polycystic Ovary Syndrome 2Obesity 2Leiomyoma 2Infertility 2Overweight 1Ovarian Neoplasms 1Osteoporosis 1Neoplasms 1Myocardial Ischemia 1Heart Diseases 1Gliosarcoma 1Glioblastoma 1Coronary Disease 1Colonic Neoplasms 1Cardiovascular Diseases 1Breast Neoplasms 1Bone Diseases 1Anovulation 1

Interventions

Antineoplastic Agents 3Nutrition Assessment 2Mass Screening 2Echocardiography 2Blood Specimen Collection 2liposomal doxorubicin 1Vitamin E 1Vitamin D 1Vital Signs 1Tomography, X-Ray Computed 1Tomography, Emission-Computed 1Therapeutics 1Surveys and Questionnaires 1Specimen Handling 1Progestins 1Positron-Emission Tomography 1Methods 1Magnetic Resonance Imaging 1Interviews as Topic 1Immunomodulating Agents 1Immune Checkpoint Inhibitors 1Hormone Replacement Therapy 1Hematologic Tests 1Exercise Test 1Estrogens 1Estrogen Replacement Therapy 1Educational Status 1Dietary Supplements 1Diet, Fat-Restricted 1Diagnosis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Heart Diseases × Progestins × Clear all
NCT00000611 2016-04-15

Women's Health Initiative (WHI)

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed
BreastGastrointestinal

Bone Diseases, Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Coronary Disease, Heart Diseases, Osteoporosis, Myocardial Ischemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡